Data presentations including the extended LIBERTY studies to highlight the long-term treatment goals of ZYMFENTRA™, the first and only FDA-approved subcutaneous…
REDWOOD CITY, Calif., May 16, 2024 /PRNewswire/ — Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated…
NEW YORK, May 16, 2024 /PRNewswire/ — Seelos Therapeutics, Inc. (Nasdaq: SEEL) (“Seelos” or the “Company”), a clinical-stage biopharmaceutical company…
Rapid urbanization and industrialization, along with the growing constriction sector in emerging economies like China, India, Brazil, Mexico and South…